Development

INSIGHTS ON DRUG DEVELOPMENT

KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging
Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
Episodic Vs. Continuous Readiness: Which Operating Model Is Carrying Your Biotech Forward?
Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.
Reducing Cycle Time By 88% Through Strategic Solvent Replacement In Pharmaceutical Development
Replacing methylene chloride in a slow, labor-intensive API step led to a single-solvent, one-pot process with a shorter reaction time and improved yield and purity.
How The Accelerator™ Drug Development Model Enhances eNPV
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering
7/31/2025

Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.
Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™
5/22/2026

Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.
Looking Beyond Solubility And Process Performance
9/2/2026

Solvent selection for spray-dried dispersions significantly impacts drug performance, scalability, and supply chains. Early, structured solvent choice is vital for successful manufacturing and commercialization.
Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution
8/17/2026

Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.
Embedded AI Is The Future Of Biopharmaceutical Recipe Creation
4/28/2026

AI-assisted recipe creation works differently across MES and DCS environments. Where the AI sits in the automation architecture, embedded or added on, shapes how well it handles GMP-scale complexity.

MaxPeak Premier Columns For Protein SEC Analysis

MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
Extractables And Leachables (E&L) Control Strategy

As E&L requirements become more complex, organizations need risk-based strategies that connect scientific assessment, regulatory readiness, and lifecycle management to reduce development risk.
Sandwich ELISA Assays For Unparalleled Simplicity And Effectiveness

SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
Predict Smarter. De-Risk Earlier.

Developability liabilities that surface late leave little room to re-engineer. Standardized assay data and complete datasets support earlier risk detection, more reliable AI predictions, and more.
An Alternative Suitable For High-Risk Applications

Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.